115 related articles for article (PubMed ID: 37792315)
41. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
[TBL] [Abstract][Full Text] [Related]
42. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
43. Dual-Activated Nano-Prodrug for Chemo-Photodynamic Combination Therapy of Breast Cancer.
Lu Z; Xu G; Yang X; Liu S; Sun Y; Chen L; Liu Q; Liu J
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555298
[TBL] [Abstract][Full Text] [Related]
44. Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.
Ma X; Huang X; Moore Z; Huang G; Kilgore JA; Wang Y; Hammer S; Williams NS; Boothman DA; Gao J
J Control Release; 2015 Feb; 200():201-11. PubMed ID: 25542645
[TBL] [Abstract][Full Text] [Related]
45. Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy.
Zhang L; Zhang S; Li M; Li Y; Xiong H; Jiang D; Li L; Huang H; Kang Y; Pang J
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111956. PubMed ID: 33812584
[TBL] [Abstract][Full Text] [Related]
46. Reactive oxygen species responsive nanoprodrug to treat intracranial glioblastoma.
Lee BS; Amano T; Wang HQ; Pantoja JL; Yoon CW; Hanson CJ; Amatya R; Yen A; Black KL; Yu JS
ACS Nano; 2013 Apr; 7(4):3061-77. PubMed ID: 23557138
[TBL] [Abstract][Full Text] [Related]
47. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
Li Y; Chen X; Ji J; Li L; Zhai G
Carbohydr Polym; 2021 Mar; 255():117393. PubMed ID: 33436222
[TBL] [Abstract][Full Text] [Related]
48. H
Ou K; Kang Y; Chen L; Zhang X; Chen X; Zheng Y; Wu J; Guan S
Biomater Sci; 2019 May; 7(6):2491-2498. PubMed ID: 30957821
[TBL] [Abstract][Full Text] [Related]
49. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
50. Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin.
Tan S; Wang G
Biomed Pharmacother; 2018 Jun; 102():55-63. PubMed ID: 29549729
[TBL] [Abstract][Full Text] [Related]
51. Engineering Transferrin-Decorated Pullulan-Based Prodrug Nanoparticles for Redox Responsive Paclitaxel Delivery to Metastatic Lung Cancer Cells.
Zhao X; Guo H; Bera H; Jiang H; Chen Y; Guo X; Tian X; Cun D; Yang M
ACS Appl Mater Interfaces; 2023 Jan; 15(3):4441-4457. PubMed ID: 36633929
[TBL] [Abstract][Full Text] [Related]
52. Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug.
Liu Y; Bajjuri KM; Liu C; Sinha SC
Mol Pharm; 2012 Jan; 9(1):168-75. PubMed ID: 22044266
[TBL] [Abstract][Full Text] [Related]
53. NIR-triggered high-efficient photodynamic and chemo-cascade therapy using caspase-3 responsive functionalized upconversion nanoparticles.
Zhao N; Wu B; Hu X; Xing D
Biomaterials; 2017 Oct; 141():40-49. PubMed ID: 28666101
[TBL] [Abstract][Full Text] [Related]
54. Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer.
Tian X; Bera H; Guo X; Xu R; Sun J; He Z; Cun D; Yang M
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56858-56872. PubMed ID: 34806372
[TBL] [Abstract][Full Text] [Related]
55. GSH/ROS Dual-Responsive Supramolecular Nanoparticles Based on Pillar[6]arene and Betulinic Acid Prodrug for Chemo-Chemodynamic Combination Therapy.
Zhu P; Luo W; Qian J; Meng C; Shan W; Xu Z; Zhang W; Liu X; Ling Y
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641443
[TBL] [Abstract][Full Text] [Related]
56. Reactive oxygen species-responsive nanoprodrug with quinone methides-mediated GSH depletion for improved chlorambucil breast cancers therapy.
Luo CQ; Zhou YX; Zhou TJ; Xing L; Cui PF; Sun M; Jin L; Lu N; Jiang HL
J Control Release; 2018 Mar; 274():56-68. PubMed ID: 29409835
[TBL] [Abstract][Full Text] [Related]
57. Synergistic Photochemo Effects Based on Light-Activatable Dual Prodrug Nanoparticles for Effective Cancer Therapy.
Liu ZY; Chen G; Wang X; Xu RC; Wang F; Qi ZR; Sun JL; Zhang GC; Miao Y; Shen XZ; Zhu JM; Weng SQ; Chen H; Li Y
Adv Healthc Mater; 2023 Oct; 12(27):e2301133. PubMed ID: 37311013
[TBL] [Abstract][Full Text] [Related]
58. The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer.
Zhang W; Xia L; Ren X; Cui M; Liu T; Ling C; Xu Y; Deng D; Zhang X; Gu Y; Wang P
Biomater Sci; 2020 Nov; 8(21):5941-5954. PubMed ID: 32966407
[TBL] [Abstract][Full Text] [Related]
59. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H
Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789
[TBL] [Abstract][Full Text] [Related]
60. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
